(Q64150449)
Statements
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Sarilumab in Patients With Giant Cell Arteritis (English)
0 references
20 November 2018
0 references
July 2021
0 references
360
0 references
50 year
0 references